Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii

Kekkaku

Volumn 81, Issue 7, 2006, Pages 475-479

  Yoshida, Shiomi ^a   Suzuki, Katsuhiro ^a   Tsuyuguchi, Kazunari ^a   Iwamoto, Tomotada ^b   Tomita, Motohisa ^a   Okada, Masaji ^a   Sakatani, Mitsunori ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b KOBE INSTITUTE OF HEALTH   (Japan)

Author keywords

Drug susceptibility test; Mycobacterium kansasii; Rifampicin resistance; rpoB mutations

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; DRUG EFFECT; GENETICS; MUTATION; MYCOBACTERIUM KANSASII;

DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MUTATION; MYCOBACTERIUM KANSASII; RIFAMPIN;

EID: 33748644908     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. The Mycobacteriosis Research Group of the Japanese National Chest Hospitals: Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. Chest. 1983; 83: 890-892.
2. American Thoracic Society: Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med. 1997; 156: S1-S25.
3. Yates MD, Collins CH: Sensitivity of opportunist mycobacteria to rifampicin and ethambutol. Tubercle. 1981; 62: 117-121.
4. Wallace RJ Jr, Dunbar D, Brown BA, et al.: Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis. 1994; 18: 736-743.
5. Klein JL, Brown TJ, French GL: Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations. Antimicrob Agents Chemother. 2001; 45: 3056-3058.
6. Japanese source
7. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. National Committee for Clinical Laboratory Standards document. 2003; M24-A: 23.
8. Wallace RJ Jr, Nash DR, Steele LC, et al.: Susceptibility testing of slowly growing mycobacteria by microdilution MIC method with 7H9 broth. J Clin Microbiol. 1986; 24: 976-981.
9. Telenti A, Imboden P, Marchesi F, et al.: Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341: 647-650.
10. Morlock GP, Plikaytis BB, Crawford JT: Characterization of spontaneous in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother. 2000; 44: 3298-3301.
11. Ahn CH, Wallace RJ Jr, Steele LC, et al.: Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii. Am Rev Respir Dis. 1987; 135: 10-16.